Core Viewpoint - The company has successfully completed the public leasing of its property located at 27 Yanling Lane, Qinhuai District, Nanjing, to Wangu Company, generating stable rental income over a 13-year lease term [1][2]. Group 1: Leasing Process - The company’s board approved the public leasing of the property on June 23-25, 2025, with a starting annual rent of 7.1155 million yuan [1]. - The total area for lease is 13,325.11 square meters, with a lease term of 13 years, including a 6-month rent-free period [1]. - The total expected rental income over the lease term is approximately 97.0973 million yuan, with a 5% increase in rent every three years starting from the fourth year [1][2]. Group 2: Progress of Leasing - The property was publicly listed for lease from July 16 to July 29, 2025, attracting one qualified bidder, Wangu Company [2]. - The final leasing agreement was confirmed on August 20, 2025, with the same annual rent of 7.1155 million yuan and a total lease amount of 97.0973 million yuan [2]. Group 3: Tenant Information - Wangu Company is based in Nanjing, with a registered capital of 66.6667 million yuan and operates in various sectors including enterprise management and property management [3]. - The major shareholder of Wangu Company is Jiangsu Wangu Financial Management Co., Ltd., holding 73.8% of its shares, and there is no related party relationship between the company and Wangu [4]. Group 4: Impact on the Company - The leasing of the property is expected to enhance the company's asset utilization and optimize resource allocation, providing a long-term stable rental income [4].

Core Points - Nanjing Pharmaceutical Co., Ltd. announced the progress of leasing a property located at 27 Yanling Lane, Qinhuai District, Nanjing [1] - The board of directors approved the public listing for lease from June 23 to June 25, 2025, with an initial annual rent of 7.1155 million yuan and a lease term of 13 years, expecting total rental income of 97.0973 million yuan [1] - The solicitation for tenants took place from July 16 to July 29, with only Wangu Enterprise Management Group Co., Ltd. meeting the qualification criteria [1] - On August 20, the company received a confirmation of transaction, with Wangu Company as the lessee at the agreed price of 7.1155 million yuan per year, totaling 97.0973 million yuan [1] - Wangu Company has a registered capital of 66.6667 million yuan and is not related to Nanjing Pharmaceutical [1]

Core Viewpoint - Nanjing Pharmaceutical (600713) plans to lease a property located at 27 Yanling Lane, Qinhuai District, Nanjing through a public listing, with an estimated first-year rental value of 7.1155 million yuan based on the assessment date [1] Summary by Relevant Sections - **Property Details** - The total area of the property is 13,325.11 square meters [1] - The lease term is set for 13 years (156 months), with a 6-month rent-free period [1] - **Financial Projections** - Rent will be paid quarterly, with the rental price remaining unchanged for the first three years [1] - Starting from the fourth year, the rent will increase by 5% every three years based on the previous year's rent [1] - The total expected rental income over the 13-year lease period is approximately 97.0973 million yuan [1] - **Transaction Process** - The final transaction price and the lessee will be determined based on the results of the public listing [1]